Drugs Containing Excipient (Inactive Ingredient) GLYCERYL MONOSTEARATE
✉ Email this page to a colleague
Branded drugs containing GLYCERYL MONOSTEARATE excipient, and estimated key patent expiration / generic entry dates
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Allergan Inc | VANIQA | eflornithine hydrochloride | 0023-4857 | GLYCERYL MONOSTEARATE | |
Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | PREMARIN | conjugated estrogens | 0046-0872 | GLYCERYL MONOSTEARATE | |
Parke-Davis Div of Pfizer Inc | NITROSTAT | nitroglycerin | 0071-0417 | GLYCERYL MONOSTEARATE | |
Novartis Pharmaceuticals Corporation | HYCAMTIN | topotecan | 0078-0672 | GLYCERYL MONOSTEARATE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Generic drugs containing GLYCERYL MONOSTEARATE excipient
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.